CEL SCI (CVM) CEO awarded 1,682 shares of common stock

Rhea-AI Filing Summary

KERSTEN GEERT R reported acquisition or exercise transactions in this Form 4 filing.

CEL SCI CORP reported that Chief Executive Officer Geert R. Kersten received a stock grant of 1,682 shares of common stock on March 31, 2026. The grant was valued at $3.21 per share. Following this award, he directly holds 122,497 common shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider KERSTEN GEERT R

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,682	$3.21	$5K

Holdings After Transaction: Common Stock — 122,497 shares (Direct)

Footnotes (1)

Key Figures

Stock grant size: 1,682 shares Grant value per share: $3.21 per share Shares held after grant: 122,497 shares

3 metrics

Stock grant size 1,682 shares Common Stock grant to CEO on March 31, 2026

Grant value per share $3.21 per share Valuation used for the 1,682-share award

Shares held after grant 122,497 shares CEO’s direct common stock holdings post-transaction

Key Terms

Common Stock, Grant, award, or other acquisition, Form 4

3 terms

Common Stock financial

"security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KERSTEN GEERT R

(Last) (First) (Middle)

8229 BOONE BLVD

STE 802

(Street)

VIENNA VIRGINIA 22182

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CEL SCI CORP [ CVM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/31/2026		A		1,682	A	$3.21	122,497	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Geert Kersten	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CEL SCI (CVM) report for its CEO?

CEL SCI reported that CEO Geert R. Kersten received a grant of 1,682 shares of common stock. The transaction is coded as a grant, award, or other acquisition, reflecting equity-based compensation rather than an open-market purchase or sale.

At what price were the new CEL SCI (CVM) shares granted to the CEO?

The 1,682 CEL SCI common shares granted to the CEO were valued at $3.21 per share. This price represents the transaction value used for the equity award and does not indicate an open-market trade or a negotiated purchase transaction.

How many CEL SCI (CVM) shares does the CEO hold after this Form 4 transaction?

After receiving the 1,682-share grant, CEL SCI’s CEO directly holds 122,497 shares of common stock. This figure reflects his direct ownership position reported in the Form 4 immediately following the non-derivative equity award transaction.

Was the CEL SCI (CVM) CEO’s Form 4 transaction a purchase or a compensation grant?

The Form 4 shows a compensation-related grant, not an open-market purchase. The transaction code “A” and description “Grant, award, or other acquisition” indicate the CEO received shares as an equity award rather than buying them in the market.

Does the CEL SCI (CVM) Form 4 show any stock sales by the CEO?

No stock sales are reported in this Form 4. The filing shows only one non-derivative transaction, a grant of 1,682 common shares to the CEO, with no dispositions or derivative exercises disclosed in the accompanying transaction summary.